Magnetic poly ε-caprolactone nanoparticles containing Fe₃O₄ and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model

References

• Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S, Lubbe AS. Locoregional cancer treatment with magnetic drug targeting. Cancer Res 2000; 60: 6641–6648
   PubMed Web of Science ®Google Scholar
• Cattel L, Ceruti M, Dosio F. From conventional to stealth liposomes: A new frontier in cancer chemotherapy. J Chemother 2004; 16(Suppl 4)94–97
   PubMedGoogle Scholar
• Cavallaro G, Mariano L, Salmaso S, Caliceti P, Gaetano G. Folate-mediated targeting of polymeric conjugates of gemcitabine. Int J Pharm 2006; 307(2)258–269
   PubMed Web of Science ®Google Scholar
• Chawla JS, Amiji MM. Biodegradable poly(e-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002; 249: 127–138
   PubMed Web of Science ®Google Scholar
• Chawla JS, Amiji MM. Cellular uptake and concentration of tamoxifen upon administration in poly(e-caprolactone) nanoparticles. AAPS Pharm Sci 2003; 5: E3
   PubMedGoogle Scholar
• Delie F, Berton M, Allemann E, Gurny R. Comparison of two methods of encapsulation of an oligonucleotide into poly (d,l-lactic acid) particles. Int J Pharm 2001; 214: 25–30
   PubMed Web of Science ®Google Scholar
• El-Kareh AW, Secomb TW. Theoretical models for drug delivery to solid tumors. Crit Rev Biomed Eng 1997; 25: 503–571
   PubMed Web of Science ®Google Scholar
• Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH, Bulte JWM. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003; 228: 480–487
   PubMed Web of Science ®Google Scholar
• Gaur U, Sahoo SK, Tapas KD, Ghosh PC, Maitra A, Ghosh PK. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm 2000; 202: 1–10
   PubMed Web of Science ®Google Scholar
• Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26: 3995–4021
   PubMed Web of Science ®Google Scholar
• Hafeli UO. Magnetically modulated therapeutic systems. Int J Pharm 2004; 277: 19–24
   PubMed Web of Science ®Google Scholar
• Hamoudeh M, Fessi H. Preparation, characterization and surface study of poly-epsilon caprolactone magnetic microparticles. J Colloid Interface Sci 2006; 300: 584–590
   PubMed Web of Science ®Google Scholar
• Hamoudeh M, Faraj AA, Canet-Soulas E, Bessueille F, Leonard D, Fessi H. Elaboration of PLLA-based superparamagnetic nanoparticles: Characterization, magnetic behaviour study and in vitro relaxivity evaluation. Int J Pharm 2007; 338((1–2))248–257
   PubMedGoogle Scholar
• Haq M, Shafii A, Zervos EE, Rosemurgy AS. Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer. Cancer Res 2000; 60: 3207–3211
   PubMed Web of Science ®Google Scholar
• Hombreiro Perez M, Zinutti C, Lamprecht A, Ubrich N, Astier A, Hoffman M, Bodmeier R, Maincent P. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J Control Release 2000; 65(3)429–438
   PubMed Web of Science ®Google Scholar
• Iannone A, Magin RL, Walczak T, Federico M, Swartz HM, Tomasi A, Vannini V. Blood clearance of dextran magnetite particles determined by a non-invasive in vivo ESR method. Magn Reson Med 1991; 22: 435–442
   PubMed Web of Science ®Google Scholar
• Immordino ML, Brusa P, Rocco F, Arpicco S, Ceruti M, Cartel L. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. J Control Release 2004; 100(3)331–346
   PubMed Web of Science ®Google Scholar
• Jackson JK, Liang LS, Hunter WL, Reynolds M, Sandberg JA, Springate C, Burt HM. The encapsulation of ribozymes in biodegradable polymeric matrices. Int J Pharm 2002; 243: 43–55
   PubMed Web of Science ®Google Scholar
• Jain RK. Delivery of molecular medicine to solid tumors. Science 1996; 271: 1079–1080
   PubMed Web of Science ®Google Scholar
• Johnson J, Kent T, Koda J, Peterson C, Rudge S, Tapolsky G. The MTC technology: A platform technology for the site-specific delivery of pharmaceutical agents. Eur Cell Mater 2002; 3: 12–15
   Google Scholar
• Kim CK, Lim SJ. Recent progress in drug delivery systems for anticancer agents. Arch Pharm Res 2001; 25: 229–239
   Web of Science ®Google Scholar
• Liggins R, D'armours S, Demetrick JS, Machan LS, Burt HM. Paclitaxel loaded poly(l-lactic acid) microspheres for the prevention of intraperitoneal carcinomatosis after a surgical repair and tumor cell spill. Biomaterials 2000; 21: 1959–1969
   PubMed Web of Science ®Google Scholar
• Lubbe AS, Bergemann C, Huhnt W, Fricke T, Riess H, Brock JW, Huhn D. Preclinical experiences with magnetic drug targeting: Tolerance and efficacy. Cancer Res 1996a; 56: 4694–4701
   PubMed Web of Science ®Google Scholar
• Lubbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K, Matthias M, Dorken B, Herrmann F, Gurtler R, Hohenberger P, Haas N, Sohr R, Sander B, Lemke AJ, Ohlendorf D, Huhnt W, Huhn D. Clinical experiences with magnetic drug targeting: A phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 1996b; 56: 4686–4693
   PubMed Web of Science ®Google Scholar
• Lubbe AS, Alexiou C, Bergemann C. Clinical applications of magnetic drug targeting. J Surg Res 2001; 95: 200–206
   PubMed Web of Science ®Google Scholar
• Mitra S, Gaur U, Ghosh PC, Maitra AN. Tumor targeted delivery of encapsulated dextran–doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 2001; 74: 317–323
   PubMed Web of Science ®Google Scholar
• Moses MA, Brem H, Langer R. Advancing the field of drug delivery: Taking aim at cancer. Cancer Cell 2003; 4: 337–341
   PubMed Web of Science ®Google Scholar
• Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of poly (d,l-lacide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm 1999; 187: 143–152
   PubMed Web of Science ®Google Scholar
• Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Further application of a modified spontaneous emulsification solvent diffusion method to various types of PLGA and PLA polymers for preparation of nanoparticles. Powder Technol 2000; 107: 137–143
   Web of Science ®Google Scholar
• Nishioka Y, Yoshino H. Lymphatic targeting with nanoparticulate system. Adv Drug Deliv Rev 2001; 47: 55–64
   PubMed Web of Science ®Google Scholar
• Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E. Pseudolatex preparation using a novel emulsion-diffusion process involving direct displacement of partially water-miscible solvents by distillation. Int J Pharm 1999; 188: 155–164
   PubMed Web of Science ®Google Scholar
• Widder KJ, Senyei AE, Scarpelli DG. Magnetic microspheres: A model system of site specific drug delivery in vivo. Proc Soc Exp Biol Med 1978; 158: 141–146
   PubMed Web of Science ®Google Scholar
• Widder KJ, Morris RM, Poore GA, Howard DP, Senyei AE. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicine: Total remission in Yoshida sarcoma bearing rats. Eur Cancer Clin Oncol 1983; 19: 135–139
   Web of Science ®Google Scholar
• Xiaoning A, Zhixing S. Characterization and application of high magnetic property chitosan particles. J Appl Polym Sci 2001; 81: 1175–1181
   Web of Science ®Google Scholar
• Yang J, Lee H, Hyung W, Park S-B, Haam S. Magnetic PECA nanoparticles as drug carriers for targeted delivery: Synthesis and release characteristics. J Microencapsulation 2006a; 23(2)203–212
   PubMed Web of Science ®Google Scholar
• Yang J, Park SB, Yoon HG, Huh YM, Haam S. Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int J Pharm 2006b; 324(2)185–190
   PubMed Web of Science ®Google Scholar
• Zaitesev VS, Filimonov DS, Presnyakov IA, Gambino RJ, Chu B. Physical and chemical properties of magnetite and magnetite-polymer nanoparticles and their colloidal dispersions. J Colloid Interface Sci 1999; 212: 49–57
   PubMed Web of Science ®Google Scholar